Zosano Pharma (zsan) Priced

Developing a transdermal formulation of an approved osteoporosis treatment.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $2.84 -0.28 (-9.0%)
First Day Return 0.1%
Return from IPO -71.6%
 
Zosano Pharma IPO News more
  • .
IPO Data
IPO File Date 06/24/2014
Offer Price $11.00
Price Range $10.00 - $12.00
Offer Shares (mm) 4.5
Deal Size ($mm) 50
 
IPO Data
IPO Date 01/26/2015
Offer Price $11.00
Price Range $10.00 - $12.00
Offer Shares (mm) 4.5
Deal Size ($mm) $50
 
Underwriters
more
Business Overview
Developing a transdermal formulation of an approved osteoporosis treatment.
Developing a transdermal formulation of an approved osteoporosis treatment.
more
Company Data
Headquarters Fremont, CA
Founded 2007
Employees 29
Website www.zosanopharma.com
 

Performance vs. IPO Index (IPOUSA)